董事介绍
注：董事持股数取自最新公司公告
| 姓名 | 性别 | 职位 | 年龄 | 薪酬 | 持股数(万股) | 截止日期 |
|---|---|---|---|---|---|---|
| Sarah Marriott | 女 | Secretary and Director | 43 | 未披露 | 未持股 | 2020-06-12 |
高管介绍
注：高管持股数取自最新公司公告
| 姓名 | 性别 | 职位 | 年龄 | 薪酬 | 持股数(万股) | 截止日期 |
|---|---|---|---|---|---|---|
| Scott Perlen | 男 | Chief Financial Officer | 45 | 未披露 | 未持股 | 2020-06-12 |
| Scott Platshon | 男 | Chief Operating Officer | 28 | 未披露 | 未持股 | 2020-06-12 |
| Caroline Stout | 女 | Chief Investment Officer | 29 | 未披露 | 未持股 | 2020-06-12 |
| Sarah Marriott | 女 | Secretary and Director | 43 | 未披露 | 未持股 | 2020-06-12 |
| Oleg Nodelman | 男 | Chief Executive Officer | 43 | 未披露 | 未持股 | 2020-06-12 |
董事简历
中英对照 | 中文 | 英文- Sarah Marriott
-
自2020年4月成立以来，Sarah Marriott一直担任我们的秘书和董事会成员。Marriott女士于2014年加入ECOR1，是公司的首席运营官和首席合规官，在那里她负责运营，监管和合规问题。任职ECOR1公司之前，她曾担任加州索拉诺县的副地方检察官。担任检察官之前，Marriott女士在旧金山的Orrick，Herrington&Sutcliffe LLP执业，在那里她处理商业诉讼事务。Marriott女士此前在联邦第十巡回上诉法院（Federal Court of Appeals for the Tenth Circuit）完成文书工作。Marriott女士持有加州大学伯克利分校（University of California，Berkeley）的法律学位，以及阿默斯特学院（Amherst College）的文学学士学位。
Sarah Marriott has served as our Secretary and on our board of directors since our inception in April 2020. Ms. Marriott joined EcoR1 in 2014 and is the firm's Chief Operating Officer and Chief Compliance Officer, where she is responsible for operational, regulatory and compliance issues. Prior to EcoR1, she served as a Deputy District Attorney in Solano County, California. Prior to serving as a prosecutor, Ms. Marriott practiced at Orrick, Herrington & Sutcliffe LLP in San Francisco, where she handled commercial litigation matters. Ms. Marriott previously completed a clerkship on the federal Court of Appeals for the Tenth Circuit. Ms. Marriott holds a law degree from the University of California, Berkeley, and a Bachelor of Arts degree from Amherst College. - 自2020年4月成立以来，Sarah Marriott一直担任我们的秘书和董事会成员。Marriott女士于2014年加入ECOR1，是公司的首席运营官和首席合规官，在那里她负责运营，监管和合规问题。任职ECOR1公司之前，她曾担任加州索拉诺县的副地方检察官。担任检察官之前，Marriott女士在旧金山的Orrick，Herrington&Sutcliffe LLP执业，在那里她处理商业诉讼事务。Marriott女士此前在联邦第十巡回上诉法院（Federal Court of Appeals for the Tenth Circuit）完成文书工作。Marriott女士持有加州大学伯克利分校（University of California，Berkeley）的法律学位，以及阿默斯特学院（Amherst College）的文学学士学位。
- Sarah Marriott has served as our Secretary and on our board of directors since our inception in April 2020. Ms. Marriott joined EcoR1 in 2014 and is the firm's Chief Operating Officer and Chief Compliance Officer, where she is responsible for operational, regulatory and compliance issues. Prior to EcoR1, she served as a Deputy District Attorney in Solano County, California. Prior to serving as a prosecutor, Ms. Marriott practiced at Orrick, Herrington & Sutcliffe LLP in San Francisco, where she handled commercial litigation matters. Ms. Marriott previously completed a clerkship on the federal Court of Appeals for the Tenth Circuit. Ms. Marriott holds a law degree from the University of California, Berkeley, and a Bachelor of Arts degree from Amherst College.
高管简历
中英对照 | 中文 | 英文- Scott Perlen
自2020年4月成立以来，Scott Perlen一直是我们的首席财务官。Perlen先生自2019年加入Ecor1以来一直担任该公司的首席财务官。他负责Ecor1公司及其投资基金的会计和财务，以及日常贸易业务的基金。在2019年加入Ecor1之前，Perlen先生在芝加哥投资公司Sheffield Asset Management，LLC担任了7年的首席财务官。任职Sheffield公司之前，Perlen先生曾担任Grosvenor Capital Management，LP（另类资产行业的全球领导者）的Vice President。在Grosvenor的7年中，Perlen先生管理着一个致力于为多家投资公司经理提供外包首席财务官职能的集团，还协助对基础投资公司进行运营尽职调查审查。在2005年加入Grosvenor之前，Perlen先生是美国银行（Bank of America）的助理Vice President，专注于银行衍生品业务的操作风险和会计。Perlen从1997年到2002年管理昇兴股份Capital Partners，LLC（一家位于圣地亚哥的投资公司）的运营和基金会计。Perlen先生于1997年在伊利诺伊大学香槟分校（University of Illinois at Urbana-Champaign）获得金融学理学学士学位。
Scott Perlen has been our Chief Financial Officer since our inception in April 2020. Mr. Perlen has been the Chief Financial Officer of EcoR1 since joining the firm in 2019. He oversees accounting and finance for EcoR1 and its investment funds as well as the funds’ day to day trade operations. Prior to joining EcoR1 in 2019 Mr. Perlen served as Chief Financial Officer for seven years at Sheffield Asset Management, LLC, a Chicago-based investment firm. Prior to Sheffield, Mr. Perlen was a Vice President at Grosvenor Capital Management, LP, a global leader in the alternative asset industry. During his seven years at Grosvenor, Mr. Perlen managed a group dedicated to providing outsourced CFO functionality to a number of investment firm managers and also assisted in performing operational due diligence reviews on underlying investment firms. Prior to joining Grosvenor in 2005 Mr. Perlen was an Assistant Vice President at Bank of America, focusing on operational risk and accounting for the bank’s derivatives business. From 1997 to 2002 Mr. Perlen managed the operations and fund accounting at Sunrise Capital Partners, LLC, a San Diego-based investment firm. Mr. Perlen received his Bachelor of Science in Finance from the University of Illinois at Urbana-Champaign in 1997.- 自2020年4月成立以来，Scott Perlen一直是我们的首席财务官。Perlen先生自2019年加入Ecor1以来一直担任该公司的首席财务官。他负责Ecor1公司及其投资基金的会计和财务，以及日常贸易业务的基金。在2019年加入Ecor1之前，Perlen先生在芝加哥投资公司Sheffield Asset Management，LLC担任了7年的首席财务官。任职Sheffield公司之前，Perlen先生曾担任Grosvenor Capital Management，LP（另类资产行业的全球领导者）的Vice President。在Grosvenor的7年中，Perlen先生管理着一个致力于为多家投资公司经理提供外包首席财务官职能的集团，还协助对基础投资公司进行运营尽职调查审查。在2005年加入Grosvenor之前，Perlen先生是美国银行（Bank of America）的助理Vice President，专注于银行衍生品业务的操作风险和会计。Perlen从1997年到2002年管理昇兴股份Capital Partners，LLC（一家位于圣地亚哥的投资公司）的运营和基金会计。Perlen先生于1997年在伊利诺伊大学香槟分校（University of Illinois at Urbana-Champaign）获得金融学理学学士学位。
- Scott Perlen has been our Chief Financial Officer since our inception in April 2020. Mr. Perlen has been the Chief Financial Officer of EcoR1 since joining the firm in 2019. He oversees accounting and finance for EcoR1 and its investment funds as well as the funds’ day to day trade operations. Prior to joining EcoR1 in 2019 Mr. Perlen served as Chief Financial Officer for seven years at Sheffield Asset Management, LLC, a Chicago-based investment firm. Prior to Sheffield, Mr. Perlen was a Vice President at Grosvenor Capital Management, LP, a global leader in the alternative asset industry. During his seven years at Grosvenor, Mr. Perlen managed a group dedicated to providing outsourced CFO functionality to a number of investment firm managers and also assisted in performing operational due diligence reviews on underlying investment firms. Prior to joining Grosvenor in 2005 Mr. Perlen was an Assistant Vice President at Bank of America, focusing on operational risk and accounting for the bank’s derivatives business. From 1997 to 2002 Mr. Perlen managed the operations and fund accounting at Sunrise Capital Partners, LLC, a San Diego-based investment firm. Mr. Perlen received his Bachelor of Science in Finance from the University of Illinois at Urbana-Champaign in 1997.
- Scott Platshon
Scott Platshon自2020年9月以来一直担任我们的董事会成员。Platshon先生目前担任投资公司ECOR1的负责人，他于2015年10月加入该公司，在那里他负责对生物技术公司进行尽职调查和分析，以寻找价值导向的投资机会。Platshon从2014年9月到2015年9月担任Aquilo Partners（一家精品生命科学投资银行）分析师。Platshon先生拥有斯坦福大学（Stanford University）的生物工程学士学位。
Scott Platshon has served as a member of Board of Directors since February 2024. Mr. Platshon has served as a Partner at EcoR1 Capital since December 2020. Mr. Platshon was also a Principal at EcoR1 Capital from December 2017 to December 2020, and has been with EcoR1 Capital since October 2015. Prior to joining EcoR1 Capital, Mr. Platshon served as an analyst at Aquilo Partners, a San Francisco life sciences investment bank, from September 2014 to September 2015. Mr. Platshon has served on the board of directors of Kumquat Biosciences Inc. since February 2021 (prior to that he was a board observer since Augt 2019) and Ajax Therapeutics, Inc. since May 2021, and previoly served on the board of directors of Terremoto Biosciences from October 2023 to December 2024. Mr. Platshon received his B.S. in Bioengineering from Stanford University. As previoly disclosed, pursuant to the securities purchase agreement with certain institutional accredited investors affiliated with EcoR1 Capital, LLC (collectively, "EcoR1"), agreed that EcoR1 would have the right to nominate one of its partners as a member of Board of Directors, with such nomination right terminating upon the earliest of the effective date of such appointment and January 1, 2026. Pursuant to this nomination right, Mr. Platshon was designated by EcoR1 as its nominee for the Board of Directors' consideration for appointment to the Board of Directors and was appointed to the Board of Directors on February 22, 2024.- Scott Platshon自2020年9月以来一直担任我们的董事会成员。Platshon先生目前担任投资公司ECOR1的负责人，他于2015年10月加入该公司，在那里他负责对生物技术公司进行尽职调查和分析，以寻找价值导向的投资机会。Platshon从2014年9月到2015年9月担任Aquilo Partners（一家精品生命科学投资银行）分析师。Platshon先生拥有斯坦福大学（Stanford University）的生物工程学士学位。
- Scott Platshon has served as a member of Board of Directors since February 2024. Mr. Platshon has served as a Partner at EcoR1 Capital since December 2020. Mr. Platshon was also a Principal at EcoR1 Capital from December 2017 to December 2020, and has been with EcoR1 Capital since October 2015. Prior to joining EcoR1 Capital, Mr. Platshon served as an analyst at Aquilo Partners, a San Francisco life sciences investment bank, from September 2014 to September 2015. Mr. Platshon has served on the board of directors of Kumquat Biosciences Inc. since February 2021 (prior to that he was a board observer since Augt 2019) and Ajax Therapeutics, Inc. since May 2021, and previoly served on the board of directors of Terremoto Biosciences from October 2023 to December 2024. Mr. Platshon received his B.S. in Bioengineering from Stanford University. As previoly disclosed, pursuant to the securities purchase agreement with certain institutional accredited investors affiliated with EcoR1 Capital, LLC (collectively, "EcoR1"), agreed that EcoR1 would have the right to nominate one of its partners as a member of Board of Directors, with such nomination right terminating upon the earliest of the effective date of such appointment and January 1, 2026. Pursuant to this nomination right, Mr. Platshon was designated by EcoR1 as its nominee for the Board of Directors' consideration for appointment to the Board of Directors and was appointed to the Board of Directors on February 22, 2024.
- Caroline Stout
自2020年4月成立以来，Caroline Stout一直担任我们的首席投资官。她于2014年加入Ecor1公司，在那里她目前担任负责人。在Ecor1，她领导了该公司在生物技术领域的多项投资。Stout女士此前曾在纽约瑞士信贷（Credit Suisse）担任投资银行分析师。她拥有从事梦百合和生物技术领域一系列交易的经验，包括杠杆收购、首次公开发行（ipo）和后续股票募集。Stout女士以优异成绩毕业于乔治敦大学（Georgetown University），获得经济学文学学士学位，医学预科，辅修认知科学。
Caroline Stout has been our Chief Investment Officer since our inception in April 2020. Ms. Stout joined EcoR1 in 2014 where she currently serves as a Principal. At EcoR1 she has led several of the firm’s investments in the biotechnology sector. Ms. Stout previously worked as an Investment Banking Analyst at Credit Suisse in New York. She has experience working on a range of transactions in the healthcare and biotechnology sectors, including leveraged buyouts, initial public offerings and follow-on equity raises. Ms. Stout graduated magna cum laude from Georgetown University with a Bachelor of Arts in Economics, a Pre-Medical concentration, and Cognitive Science minor.- 自2020年4月成立以来，Caroline Stout一直担任我们的首席投资官。她于2014年加入Ecor1公司，在那里她目前担任负责人。在Ecor1，她领导了该公司在生物技术领域的多项投资。Stout女士此前曾在纽约瑞士信贷（Credit Suisse）担任投资银行分析师。她拥有从事梦百合和生物技术领域一系列交易的经验，包括杠杆收购、首次公开发行（ipo）和后续股票募集。Stout女士以优异成绩毕业于乔治敦大学（Georgetown University），获得经济学文学学士学位，医学预科，辅修认知科学。
- Caroline Stout has been our Chief Investment Officer since our inception in April 2020. Ms. Stout joined EcoR1 in 2014 where she currently serves as a Principal. At EcoR1 she has led several of the firm’s investments in the biotechnology sector. Ms. Stout previously worked as an Investment Banking Analyst at Credit Suisse in New York. She has experience working on a range of transactions in the healthcare and biotechnology sectors, including leveraged buyouts, initial public offerings and follow-on equity raises. Ms. Stout graduated magna cum laude from Georgetown University with a Bachelor of Arts in Economics, a Pre-Medical concentration, and Cognitive Science minor.
- Sarah Marriott
自2020年4月成立以来，Sarah Marriott一直担任我们的秘书和董事会成员。Marriott女士于2014年加入ECOR1，是公司的首席运营官和首席合规官，在那里她负责运营，监管和合规问题。任职ECOR1公司之前，她曾担任加州索拉诺县的副地方检察官。担任检察官之前，Marriott女士在旧金山的Orrick，Herrington&Sutcliffe LLP执业，在那里她处理商业诉讼事务。Marriott女士此前在联邦第十巡回上诉法院（Federal Court of Appeals for the Tenth Circuit）完成文书工作。Marriott女士持有加州大学伯克利分校（University of California，Berkeley）的法律学位，以及阿默斯特学院（Amherst College）的文学学士学位。
Sarah Marriott has served as our Secretary and on our board of directors since our inception in April 2020. Ms. Marriott joined EcoR1 in 2014 and is the firm's Chief Operating Officer and Chief Compliance Officer, where she is responsible for operational, regulatory and compliance issues. Prior to EcoR1, she served as a Deputy District Attorney in Solano County, California. Prior to serving as a prosecutor, Ms. Marriott practiced at Orrick, Herrington & Sutcliffe LLP in San Francisco, where she handled commercial litigation matters. Ms. Marriott previously completed a clerkship on the federal Court of Appeals for the Tenth Circuit. Ms. Marriott holds a law degree from the University of California, Berkeley, and a Bachelor of Arts degree from Amherst College.- 自2020年4月成立以来，Sarah Marriott一直担任我们的秘书和董事会成员。Marriott女士于2014年加入ECOR1，是公司的首席运营官和首席合规官，在那里她负责运营，监管和合规问题。任职ECOR1公司之前，她曾担任加州索拉诺县的副地方检察官。担任检察官之前，Marriott女士在旧金山的Orrick，Herrington&Sutcliffe LLP执业，在那里她处理商业诉讼事务。Marriott女士此前在联邦第十巡回上诉法院（Federal Court of Appeals for the Tenth Circuit）完成文书工作。Marriott女士持有加州大学伯克利分校（University of California，Berkeley）的法律学位，以及阿默斯特学院（Amherst College）的文学学士学位。
- Sarah Marriott has served as our Secretary and on our board of directors since our inception in April 2020. Ms. Marriott joined EcoR1 in 2014 and is the firm's Chief Operating Officer and Chief Compliance Officer, where she is responsible for operational, regulatory and compliance issues. Prior to EcoR1, she served as a Deputy District Attorney in Solano County, California. Prior to serving as a prosecutor, Ms. Marriott practiced at Orrick, Herrington & Sutcliffe LLP in San Francisco, where she handled commercial litigation matters. Ms. Marriott previously completed a clerkship on the federal Court of Appeals for the Tenth Circuit. Ms. Marriott holds a law degree from the University of California, Berkeley, and a Bachelor of Arts degree from Amherst College.
- Oleg Nodelman
Oleg Nodelman，2013年11月11日，被任命为本公司董事会成员。他是EcoR1 Capital的创始人，并从2012年10月起担任总经理，这是一家位于旧金山的价值主导型的保健行业私募投资基金。创办EcoR1 Capital之前，2001-2012，他担任 BVF Partners L.P.的投资组合经理，这是美国最古老的专业的生物技术行业对冲基金。加入BVF之前，他是Mercer Management Consulting（现Oliver Wyman）的一名顾问，这是一家专注于战略、运营、风险管理、机构变革及领导力开发的咨询公司。他现为Addex Therapeutics的董事会成员，这是一家临床阶段的生物制药公司，在瑞士证券交易所上市；也是Gladstone Institute的总裁委员会的成员。他获得了Georgetown University的科技方向的涉外服务学士学位。丰富的管理咨询经验、生物技术公司的投资经验、其它上市公司的董事任职经验，足以使他胜任本公司的董事会职务。
Oleg Nodelman has served as a member of Board of Directors since February 2025. Since October 2013, Mr. Nodelman has served as the Founder and Portfolio Manager of EcoR1 Capital LLC, a biotech foced investment advisory firm established in 2013, and one of principal stockholders. Previoly, Mr. Nodelman served as a Portfolio Manager at BVF Partners from 2001 to 2012. Mr. Nodelman earned a B.S.F.S. in Science and Technology from Georgetown University, School of Foreign Service in 1999. Mr. Nodelman has served on the board of Galapagos NV since October 2024 and AnaptysBio since April 2021. He previoly served on the board of directors of Prothena Corporation plc from December 2019 to December 2024, Nuvation Bio Inc. from February 2021 to December 2023 and Panacea Acquisition Corp. II from April 2020 to February 2021.- Oleg Nodelman，2013年11月11日，被任命为本公司董事会成员。他是EcoR1 Capital的创始人，并从2012年10月起担任总经理，这是一家位于旧金山的价值主导型的保健行业私募投资基金。创办EcoR1 Capital之前，2001-2012，他担任 BVF Partners L.P.的投资组合经理，这是美国最古老的专业的生物技术行业对冲基金。加入BVF之前，他是Mercer Management Consulting（现Oliver Wyman）的一名顾问，这是一家专注于战略、运营、风险管理、机构变革及领导力开发的咨询公司。他现为Addex Therapeutics的董事会成员，这是一家临床阶段的生物制药公司，在瑞士证券交易所上市；也是Gladstone Institute的总裁委员会的成员。他获得了Georgetown University的科技方向的涉外服务学士学位。丰富的管理咨询经验、生物技术公司的投资经验、其它上市公司的董事任职经验，足以使他胜任本公司的董事会职务。
- Oleg Nodelman has served as a member of Board of Directors since February 2025. Since October 2013, Mr. Nodelman has served as the Founder and Portfolio Manager of EcoR1 Capital LLC, a biotech foced investment advisory firm established in 2013, and one of principal stockholders. Previoly, Mr. Nodelman served as a Portfolio Manager at BVF Partners from 2001 to 2012. Mr. Nodelman earned a B.S.F.S. in Science and Technology from Georgetown University, School of Foreign Service in 1999. Mr. Nodelman has served on the board of Galapagos NV since October 2024 and AnaptysBio since April 2021. He previoly served on the board of directors of Prothena Corporation plc from December 2019 to December 2024, Nuvation Bio Inc. from February 2021 to December 2023 and Panacea Acquisition Corp. II from April 2020 to February 2021.